Use of generic drugs on the rise, data show

Share this article:
Almost two-thirds of prescriptions filled for Medicare beneficiaries are for generic, rather than brand-name, drugs, according to government data. That proportion is higher than in the under-65 age group and helps lower the projected costs of the Medicare drug benefit. The Centers for Medicare and Medicaid Services, which runs the federal program for the elderly and disabled, found that 61% of seniors’ prescriptions were for generic medications in the third quarter, the third consecutive quarter of growth in generic drug use. The National Association of Chain Drug Stores was also expected to announce that use of generic drugs rose to almost 53% of privately insured Americans, from 48% in 2005. Increased use of generics has been given as one reason why the growth in US health care spending has slowed in recent years. Generic alternatives have also allowed seniors to delay reaching the Medicare benefit’s coverage gap, also known as the “doughnut hole,” or avoid it altogether. The agency encourages the use of generic drugs, according to The Wall Street Journal report.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low ...

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Novartis may have game-changing drug

Novartis may have game-changing drug

Key opinion leaders indicate they are ready to embrace Novartis's experimental heart failure medication LCZ696. Such a move could upend heart failure treatment protocols.

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...